252 related articles for article (PubMed ID: 25023966)
41. Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study.
Bond J; Graux C; Lhermitte L; Lara D; Cluzeau T; Leguay T; Cieslak A; Trinquand A; Pastoret C; Belhocine M; Spicuglia S; Lheritier V; Leprêtre S; Thomas X; Huguet F; Ifrah N; Dombret H; Macintyre E; Boissel N; Asnafi V
J Clin Oncol; 2017 Aug; 35(23):2683-2691. PubMed ID: 28605290
[TBL] [Abstract][Full Text] [Related]
42. Cell of origin in radiation-induced premalignant thymocytes with differentiation capability in mice conditionally losing one Bcl11b allele.
Go R; Hirose S; Katsuragi Y; Obata M; Abe M; Mishima Y; Sakimura K; Kominami R
Cancer Sci; 2013 Aug; 104(8):1009-16. PubMed ID: 23663453
[TBL] [Abstract][Full Text] [Related]
43. Haploinsufficiency of Bcl11b suppresses the progression of ATM-deficient T cell lymphomas.
Pinkney KA; Jiang W; Lee BJ; Loredan DG; Li C; Bhagat G; Zha S
J Hematol Oncol; 2015 Jul; 8():94. PubMed ID: 26219558
[TBL] [Abstract][Full Text] [Related]
44. RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD.
Sakhdari A; Thakral B; Loghavi S; Kanagal-Shamanna R; Yin CC; Zuo Z; Routbort MJ; Luthra R; Medeiros LJ; Wang SA; Patel KP; Ok CY
Cancer Med; 2020 Feb; 9(3):849-858. PubMed ID: 31804006
[TBL] [Abstract][Full Text] [Related]
45. BCL11B-Mediated Epigenetic Repression Is a Crucial Target for Histone Deacetylase Inhibitors in Cutaneous T-Cell Lymphoma.
Fu W; Yi S; Qiu L; Sun J; Tu P; Wang Y
J Invest Dermatol; 2017 Jul; 137(7):1523-1532. PubMed ID: 28288848
[TBL] [Abstract][Full Text] [Related]
46. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of BCL11B induces downregulation of PTK7 and results in growth retardation and apoptosis in T-cell acute lymphoblastic leukemia.
Li K; Chen C; Gao R; Yu X; Huang Y; Chen Z; Liu Z; Chen S; Luo G; Huang X; Przybylski GK; Li Y; Zeng C
Biomark Res; 2021 Mar; 9(1):17. PubMed ID: 33663588
[TBL] [Abstract][Full Text] [Related]
48. BCL11B promotes T-cell acute lymphoblastic leukaemia cell survival via the XRCC5/C11ORF21 axis.
Yu X; Li Y; Yang P; Wang Y; Liu X; Cai L; Lai J; Zhang Y; Zha X; Przybylski GK; Xu L; Li Y
Clin Transl Med; 2024 Feb; 14(2):e1580. PubMed ID: 38317587
[No Abstract] [Full Text] [Related]
49. Genome-wide analyses identify KLF4 as an important negative regulator in T-cell acute lymphoblastic leukemia through directly inhibiting T-cell associated genes.
Li W; Jiang Z; Li T; Wei X; Zheng Y; Wu D; Yang L; Chen S; Xu B; Zhong M; Jiang J; Hu Y; Su H; Zhang M; Huang X; Geng S; Weng J; Du X; Liu P; Li Y; Liu H; Yao Y; Li P
Mol Cancer; 2015 Feb; 14():26. PubMed ID: 25644173
[TBL] [Abstract][Full Text] [Related]
50. [The Best Time of Minimal Residual Disease Monitoring for Predicting Survival and Prognosis in Children with T-Cell Acute Lymphoblastic Leukemia].
Bao H; Li TY; Wu YT; Xiao ZT; Zhang L; Luo LY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1471-1477. PubMed ID: 34627426
[TBL] [Abstract][Full Text] [Related]
51. Absence of biallelic TCRγ deletion predicts induction failure and poorer outcomes in childhood T-cell acute lymphoblastic leukemia.
Yang YL; Hsiao CC; Chen HY; Lin KH; Jou ST; Chen JS; Chang TK; Sheen JM; Yu SL; Lu MY; Cheng CN; Wu KH; Wang SC; Wang JD; Chang HH; Lin SR; Lin SW; Lin DT
Pediatr Blood Cancer; 2012 Jun; 58(6):846-51. PubMed ID: 22180181
[TBL] [Abstract][Full Text] [Related]
52. Promoter hypermethylation of BCL11B gene correlates with downregulation of gene transcription in ankylosing spondylitis patients.
Karami J; Mahmoudi M; Amirzargar A; Gharshasbi M; Jamshidi A; Aslani S; Nicknam MH
Genes Immun; 2017 Sep; 18(3):170-175. PubMed ID: 28794504
[TBL] [Abstract][Full Text] [Related]
53. CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic phenotype and resistance to induction therapy but no inferior survival after risk-adapted therapy.
Fischer L; Gökbuget N; Schwartz S; Burmeister T; Rieder H; Brüggemann M; Hoelzer D; Thiel E
Haematologica; 2009 Feb; 94(2):224-9. PubMed ID: 19109214
[TBL] [Abstract][Full Text] [Related]
54. High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
Cario G; Rhein P; Mitlöhner R; Zimmermann M; Bandapalli OR; Romey R; Moericke A; Ludwig WD; Ratei R; Muckenthaler MU; Kulozik AE; Schrappe M; Stanulla M; Karawajew L
Haematologica; 2014 Jan; 99(1):103-10. PubMed ID: 23911702
[TBL] [Abstract][Full Text] [Related]
55. Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia.
Van Vlierberghe P; Ambesi-Impiombato A; De Keersmaecker K; Hadler M; Paietta E; Tallman MS; Rowe JM; Forne C; Rue M; Ferrando AA
Blood; 2013 Jul; 122(1):74-82. PubMed ID: 23687089
[TBL] [Abstract][Full Text] [Related]
56. LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.
Malumbres R; Fresquet V; Roman-Gomez J; Bobadilla M; Robles EF; Altobelli GG; Calasanz MJ; Smeland EB; Aznar MA; Agirre X; Martin-Palanco V; Prosper F; Lossos IS; Martinez-Climent JA
Haematologica; 2011 Jul; 96(7):980-6. PubMed ID: 21459790
[TBL] [Abstract][Full Text] [Related]
57. Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma.
Xi Y; Li J; Zhang P; Bai W; Gao N; Bai W; Zhang Y; Wu Y; Ning Y
Exp Mol Pathol; 2015 Oct; 99(2):297-302. PubMed ID: 26231295
[TBL] [Abstract][Full Text] [Related]
58. Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S
BMC Cancer; 2024 Mar; 24(1):325. PubMed ID: 38459434
[TBL] [Abstract][Full Text] [Related]
59. Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.
van der Velden VH; Jacobs DC; Wijkhuijs AJ; Comans-Bitter WM; Willemse MJ; Hählen K; Kamps WA; van Wering ER; van Dongen JJ
Leukemia; 2002 Aug; 16(8):1432-6. PubMed ID: 12145681
[TBL] [Abstract][Full Text] [Related]
60. Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemia.
Grossmann V; Kern W; Harbich S; Alpermann T; Jeromin S; Schnittger S; Haferlach C; Haferlach T; Kohlmann A
Haematologica; 2011 Dec; 96(12):1874-7. PubMed ID: 21828118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
